Page last updated: 2024-08-24

bimakalim and Chronic Illness

bimakalim has been researched along with Chronic Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aidonidis, I; Lymberi, M; Molyvdas, PA; Poyatzi, A; Stamatiou, G; Stamatoyannis, N1
Baker, JE; Eells, JT; Gross, GJ; Henry, MM1

Other Studies

2 other study(ies) available for bimakalim and Chronic Illness

ArticleYear
Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Journal of cardiovascular pharmacology and therapeutics, 2009, Volume: 14, Issue:3

    Topics: Action Potentials; Anesthesia, General; Animals; Anti-Arrhythmia Agents; Benzopyrans; Cardiac Pacing, Artificial; Chronic Disease; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Infusions, Intravenous; KATP Channels; Male; Myocardial Infarction; Myocardium; Refractory Period, Electrophysiological; Swine; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation

2009
Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics?
    Circulation research, 2000, Nov-10, Volume: 87, Issue:10

    Topics: Adaptation, Physiological; Adenosine Triphosphate; Animals; Animals, Newborn; Benzopyrans; Cell Hypoxia; Chronic Disease; Cytoprotection; Decanoic Acids; Dihydropyridines; Energy Metabolism; Glyburide; Heart Ventricles; Hemodynamics; Hydroxy Acids; Hypoxia; In Vitro Techniques; Membrane Potentials; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Potassium Channel Blockers; Potassium Channels; Rabbits

2000